Avanir Pharmaceuticals (AVNR) Misses Q1 EPS by 1c

Avanir Pharmaceuticals (NASDAQ: AVNR) reported Q1 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.5 million, versus $7.2 million reported last year.

For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• United Bancshares, Inc. (UBOH) Reports Q1 EPS of $0.61
• Marten Transport (MRTN) Misses Q1 EPS by 2c